HCPLive Network


The European Medicines Agency has announced it will evaluate all medications containing testosterone for cardiovascular risk.
Short-term intensive insulin therapy can improve β-cell function in type 2 diabetes mellitus in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.
In areas with less access to ophthalmologists, fewer individuals with diabetes, diabetic retinopathy, and age-related macular degeneration receive care, according to a study published in the April issue of JAMA Ophthalmology.
The US Food and Drug Administration has approved Tanzeum (albiglutide), a once-weekly subcutaneous injection for the treatment of type 2 diabetes in adults.
A tool for diagnosing and monitoring diabetes has received 510(k) clearance from the US Food and Drug Administration.
The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.
Diabetes Upcoming Events
Diabetes Resources